Related Experiment Videos
[Vagus nerve stimulation and refractory partial epilepsies]
1Service de Neurochirurgie, Hôpital Sainte-Anne, 1 rue Cabanis, 75014 Paris, France. landre@chsa.broca.inserm.fr
Revue Neurologique
|August 28, 2004
Summary
Vagus nerve stimulation (VNS) offers an effective add-on treatment for refractory epilepsy, reducing seizure frequency by an average of 40% after two years. Patients also report improved quality of life, demonstrating VNS
Area of Science:
- Neuroscience and Neurology
- Medical Devices and Therapeutics
Context:
- Vagus nerve stimulation (VNS) has been utilized since 1988 as an adjunctive therapy for epilepsy.
- Over 20,000 patients globally have received VNS for refractory epilepsy, following five multicenter studies involving 440 patients.
Purpose:
- To evaluate the efficacy and tolerability of VNS as an add-on symptomatic treatment for refractory partial epilepsy.
- To assess the impact of VNS on seizure frequency, quality of life, and economic factors in epilepsy management.
Summary:
- VNS is effective and well-tolerated in pediatric and adult patients with refractory partial epilepsy.
- Two years of VNS treatment results in an average 40% reduction in seizure frequency, with 40-50% of patients experiencing a 50% decrease.
- Improvements in quality of life are reported even without significant seizure reduction.
Impact:
- VNS demonstrates a favorable impact on the management of refractory partial epilepsies.
- Economic surveys indicate a positive effect of VNS on healthcare management and patient outcomes.